These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 21824859)
1. [Pharmacologic treatment of osteoporosis--2011]. Lakatos P Orv Hetil; 2011 Aug; 152(33):1320-6. PubMed ID: 21824859 [TBL] [Abstract][Full Text] [Related]
2. New developments in the treatment of osteoporosis. Eriksen EF; Halse J; Moen MH Acta Obstet Gynecol Scand; 2013 Jun; 92(6):620-36. PubMed ID: 22646526 [TBL] [Abstract][Full Text] [Related]
3. Management of postmenopausal osteoporosis and the prevention of fractures. Gambacciani M; Levancini M Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322 [TBL] [Abstract][Full Text] [Related]
7. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women. Wensel TM; Iranikhah MM; Wilborn TW Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432 [TBL] [Abstract][Full Text] [Related]
8. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis. Josse R; Khan A; Ngui D; Shapiro M Curr Med Res Opin; 2013 Mar; 29(3):205-16. PubMed ID: 23297819 [TBL] [Abstract][Full Text] [Related]
9. Developments in the pharmacotherapeutic management of osteoporosis. Close P; Neuprez A; Reginster JY Expert Opin Pharmacother; 2006 Aug; 7(12):1603-15. PubMed ID: 16872263 [TBL] [Abstract][Full Text] [Related]
11. Efficacy, effectiveness and side effects of medications used to prevent fractures. Reid IR J Intern Med; 2015 Jun; 277(6):690-706. PubMed ID: 25495429 [TBL] [Abstract][Full Text] [Related]
12. [Up-to-date treatments for osteoporosis]. Bors K Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157 [TBL] [Abstract][Full Text] [Related]
13. Current options for the management of postmenopausal osteoporosis. Lecart MP; Reginster JY Expert Opin Pharmacother; 2011 Nov; 12(16):2533-52. PubMed ID: 21916810 [TBL] [Abstract][Full Text] [Related]
14. [Drugs under development for osteoporosis ]. Masuda H; Tanaka S Nihon Rinsho; 2009 May; 67(5):980-4. PubMed ID: 19432120 [TBL] [Abstract][Full Text] [Related]
15. Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis. Ström O; Jönsson B; Kanis JA Osteoporos Int; 2013 Apr; 24(4):1491-502. PubMed ID: 23224141 [TBL] [Abstract][Full Text] [Related]
18. Osteoporosis: how long should we treat? Sebba A Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):502-7. PubMed ID: 18971678 [TBL] [Abstract][Full Text] [Related]
19. Comparing clinical and economic outcomes of biologic and conventional medications in postmenopausal women with osteoporosis. Hernandez I; Zhang Y J Eval Clin Pract; 2015 Oct; 21(5):840-7. PubMed ID: 26059485 [TBL] [Abstract][Full Text] [Related]
20. Treatment of osteoporosis in older adults. Gosch M; Kammerlander C; Nicholas JA Panminerva Med; 2014 Jun; 56(2):133-43. PubMed ID: 24820095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]